Immunic Inc

Research Immunic Inc (IMUX) on Bullrun: market cap USD 209.91M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIMUX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 209.91M
• Financial periodFY2025
• Net income-USD 97.17M
• Free cash flow-USD 85.97M

Valuation Snapshot

latest market cap is USD 209.91M.

About Immunic Inc

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis.

Frequently asked questions

What is Immunic Inc's market cap?

Immunic Inc's market capitalization is USD 209.91M.

What does Immunic Inc do?

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.